Results 101 to 110 of about 533,192 (191)

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer. [PDF]

CPT Pharmacometrics Syst Pharmacol
Franzese RC, Qin L, Fu S, Rich B, Zografos E, Zierhut ML, Visser SAG.   +6 more
europepmc   +1 more source

Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors in malignant solid tumors: a meta-analysis and network meta-analysis. [PDF]

Front Immunol
Wang C, Wang N, Wu Z, Yu X, Yu X, Wang J, Li J, Han Y.   +7 more
europepmc   +1 more source

Enhanced ORR Activity of Modified Recycled Graphite-Based Anode Materials. [PDF]

ACS Omega
Sukanya S, Hoseinzade K, Bettels F, Zhang L, Wilhelm R.   +4 more
europepmc   +1 more source

Promoting reconciliation through research. [PDF]

CMAJ
Orr PH.
europepmc   +1 more source

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide. [PDF]

J Clin Sleep Med
Schmickl CN, Tripipitsiriwat A, Mokhlesi B, Mallampalli M, Nokes B, Kundel V, Page K, Finch C, Donovan L, Tadros M, Aysola RS, Zinchuk A, Zvenyach T, Badr MS, Patel SR, Orr JE, Owens RL, Lindsell C, Martin JL, Malhotra A, PARADIGM-SLEEP Investigators.   +20 more
europepmc   +1 more source

Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis of emerging clinical evidence. [PDF]

Front Immunol
Dai Y, Xiao C, Wang L, Zhou W, Bo R, Cheng Z, Pan G.   +6 more
europepmc   +1 more source

Combination immunotherapy for colorectal cancer: Clinical applications, rationale, challenges, and future perspectives. [PDF]

Cell Rep Med
Fei J, Cai C, Wu W, Shen H, Han Y, Zeng S.   +5 more
europepmc   +1 more source

Symmetry Evolution of La₂O₃ from P<b>3-</b>m1 to P6₃/mmc for Enhanced Electrocatalytic H₂O₂ Production. [PDF]

Nanomaterials (Basel)
Yuan H, Gu Y, Yang Q, Li S, Zhang J, Zhang L, Zhang Y.   +6 more
europepmc   +1 more source

Lorlatinib in patients with <i>ALK</i>-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV study. [PDF]

Future Oncol
Bearz A, Ricciardi S, Vivek Raut N, Dols MC, Chiradoni Thungappa S, Sacco PC, Thurm H, Pavlov D, Toffalorio F, Felip E.   +9 more
europepmc   +1 more source

Spin Regulation of Fe Single Site Induced by Adjacent Mg Site Achieving Excellent Oxygen Reduction Catalysis. [PDF]

Nanomicro Lett
Shi Y, Zhang Z, Bai L, Li D, Shi J, Yue Z, Yuan T, Bai J, Bai J, Leng K, Li X, Wang X, Qu Y.   +12 more
europepmc   +1 more source